At AiMorphous Health, we are leveraging a novel dual-component system that combines early blood biomarkers with a proprietary algorithm, we are the first mover in the market addressing the limitations in early detection and predictive accuracy that causes unpredictable and unpreventable thrombosis ask in strokes. Our validated biomarkers exhibit exceptional sensitivity and specificity, driving a risk model that delivers high-resolution, personalized risk assessments with unprecedented precision.
At AiMorphous Health, our mission is to safeguard the wellbeing of everyone at risk through breakthrough technology.
A system to help prevent and treat the #1 disease cause of death and debilitation, with breakthrough early blood biomarker and novel predictive AI model duplex system